Transcript Qst pro
Quantify pathology 2. Support diagnosis 3. Follow-up natural history/treatment 4. Predict future pain 5. Predict response to therapy 1. 1.Quantifying sensory function Static pain parameters Non painful modalities Hypo (-) Hypo (-) Painful modalities Hyper (+) Thresholds Quantifying sensory function Static pain parameters Non painful modalities Hypo (-) Hypo (-) Painful modalities Hyper (+) Non painful neuropathy Neuropathic pain Non neuropathic pain Quantifying sensory function Thresholds Non painful modalities Hypo (-) Hypo (-) Painful modalities Hyper (+) Non painful Neuropathy Neuropathic pain Non neuropathic pain Pfau et al 2012 2. Supporting diagnosis 23 C6-7 Radic, 8 NS neck-arm pain, 22 FM & 31 ctrls Wide QST battery at painful and contralateral sites Tampin et al, 2012 41 studies included PPT found most common QST 7 studies assessed session to session repeatability, found quite good Estimated that 45 patients are needed to distinct OA and ctrl groups for affected joint PPT דSta Standardized Mean Differences compared to controls Suokas et al, 2012 Pooled SMD (95% Conf.Int.) Suokas et al, 2012 Sequential QST on face for 10 wks 40 patients undergoing oral surgery No post surgical sensory complaints Said-Yekta et al, 2012 Said-Yekta et al, 2012 Temporal summation (TS) & Conditioned pain modulation (CPM, DNIC-like) • Psychophysical response to repetitive stimuli expressed by increased pain rating along stimulation • Equivalent to ‘wind-up’ in spinal WDR neurons Stimulus intensity Pain rating time Sarlani & Greenspan, 2005 Temp VAS CPM = ∆ VAS (VAS Post – VAS Pre) Rt Rt Lt Conditioned - pre Conditioned - post Conditioning 40 122 pre-operative patients 30 20 CPM score 10 0 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 -10 -20 -30 -40 -50 number of subjects -60 Efficient Less efficient CPM in IBS and TMD Nachmias et al 2009 Thoracotomy patients were: › Assessed for pain processing before surgery, at pain-free time: Pain thresholds Pain60 CPM (DNIC), TS › Undergone thoracotomy › Reported acute post-op pain (days 2 and 5) during: Cough Arm elevation › Reported chronic post-op pain (6-12 month) During the week previous to clinic visit Term 95% upper and lower OR CPM (DNIC) Odds Ratio (OR) 0.50 Baseline test-pain 0.89 0.54-1.47 Acute pain 1.86 1.29-2.98 Pain threshold 0.79 0.75-1.19 Surgery type [no rib #] 0.62 0.28-1.30 Gender [female] 0.62 0.26-1.35 Age 0.99 0.93-1.04 0.28-0.79 If pain modulation is involved in the generation of pain, it could also be involved in its alleviation › then If less efficient CPM leads to development of pain, improving CPM in pain patients could lead to alleviation of pain Pain assessed weekly, along: 1 baseline week 1 placebo week 1 week of 30 mg duloxetine 4 weeks of 60 mg duloxetine CPM, TS and other pain psychophysics at beginning and end. CPM predicts efficacy of duloxetine in painful diabetic neuropathy 60 50 40 R² = 0.3956 30 20 10 CPM 0 20% -10 0% -20 -30 -40 -50 -60 40% 60% 80% 100% Drug efficacy Yarnitsky et al, 2012 Predictors B coefficients Beta t P Pre treatment depression 1.08 0.27 1.45 0.171 Initial spontaneous pain 0.29 0.24 1.03 0.321 Foot MDT 5.53 0.16 0.74 0.475 Foot WDT -2.03 -0.24 -1.27 0.227 Placebo Effect -0.23 -0.14 -0.63 0.559 Pre treatment CPM 1.16 0.822 4.20 0.001 1. 2. 3. 4. 5. Quantify sensory changes – positive and negative (vs. EMG) Discern neuropathic from non neuropathic pain states Be used for follow-up on changes in sensory state, such as after surgery Predict post operative pain Predict efficacy of pain alleviating agents Yonathan Crispel And Lab staff: Irit Weismann Fogel Alon Sinai Michal Granot Iris Amor David Yarnitsky Ruth Moont Yelena Granovsky Erica Dolnikov Liat Honigman Hadas AverbuchNachman Elliot Sprecher Dorit Pud Beth Murrinson Rony Nir Rina Lev Collaborators: Elon Eisenberg Ruth Defrin Stefan Lautenbacher Eli Eliav Bob Coghill Lars ArendtNielsen Oliver WilderSmith Rami Burstein